Robertson John A
Kennedy Inst Ethics J. 1999 Jun;9(2):109-36. doi: 10.1353/ken.1999.0013.
Embryonic stem cells, which have the potential to save many lives, must be recovered from aborted fetuses or live embyros. Although tissue from aborted fetuses can be used without moral complicity in the underlying abortion, obtaining stem cells from embryos necessarily kills them, thus raising difficult questions about the use of embryonic human material to save others. This article draws on previous controversies over embryo research and distinctions between intrinsic and symbolic moral status to analyze these issues. It argues that stem cell research with spare embryos produced during infertility treatment, or even embryos created specifically for research or therapeutic purposes, is ethically acceptable and should receive federal funding.
胚胎干细胞有挽救众多生命的潜力,必须从流产胎儿或活体胚胎中获取。虽然流产胎儿的组织可以在不涉及潜在堕胎行为的道德问题的情况下使用,但从胚胎中获取干细胞必然会导致胚胎死亡,因此引发了关于使用人类胚胎材料来拯救他人的难题。本文借鉴以往关于胚胎研究的争议以及内在道德地位和象征道德地位之间的区别来分析这些问题。文章认为,利用不育治疗过程中产生的多余胚胎进行干细胞研究,甚至专门为研究或治疗目的而创造的胚胎进行干细胞研究,在伦理上是可以接受的,并且应该获得联邦资金。